Xilio Therapeutics appoints Cheryl R Blanchard to Board
April 20, 2026Xilio Therapeutics
Xilio Therapeutics has announced the appointment of Cheryl R Blanchard to the company’s board of directors. The company also announced …
Kayentis and RWS partner to improve clinical trial data confidence
April 17, 2026Research and Development RWS, kayentis
Kayentis and RWS have announced a partnership aimed at improving confidence in clinical trial data for neuroscience and other complex …
MHRA expands its pioneering AI Airlock programme with £3.6m funding boost
April 16, 2026Research and Development
The Medicines and Healthcare products Regulatory Agency (MHRA) has secured new funding to expand its AI Airlock programme, aimed at …
Ardena opens new US bioanalytical laboratory
April 15, 2026Business Services
Ardena has announced that its new GLP bioanalytical laboratory in Somerset, New Jersey in the US is operational and supporting …
Gesynta Pharma doses first patient in endometriosis phase 2 trial
April 14, 2026Research and Development Gesynta Pharma, endometriosis
Gesynta Pharma has dosed the first patient in its phase 2 clinical proof-of-concept trial of vipoglanstat. The trial, NOVA, is …
Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says
April 13, 2026Astellas Pharma, menopause
Final draft NICE guidance has recommended Veoza (fezolinetant), made by Astellas Pharma, to treat moderate to severe menopausal hot flushes …
Sandoz launches allergy relief nasal spray in Germany and Switzerland
April 9, 2026Ear Nose & throat
Sandoz has launched its azelastine and fluticasone fixed-dose-combination (FDC) nasal spray in Germany and Switzerland. In Germany the FDC over …
Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer
April 9, 2026Oncology
The Japan Pharmaceuticals and Medical Devices Agency (PMDA) has accepted the updated prescribing information for Daiichi Sankyo’s Enhertu (trastuzumab), a …
Trelleborg to take part in Medtec Japan 2026
April 8, 2026Manufacturing and Production
Trelleborg Medical Solutions will showcase its latest engineered polymer solutions for demanding medical, biotech and pharmaceutical applications at Medtec Japan …
Kainova Therapeutics expands phase I/II trial of antibody drug
April 7, 2026Research and Development
Kainova Therapeutics has announced that the first patient in the European expansion of its DOMISOL phase I/II clinical trial evaluating …
Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086
April 7, 2026Research and Development
Eisai is to begin enrolling participants in its phase 2 study, Study 202, in patients with narcolepsy. The company registered …
Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer
April 2, 2026Faron Pharmaceuticals
Faron Pharmaceuticals, a clinical-stage biopharmaceutical company, has appointed Heikki Jouttijärvi as Chief Technical Officer (CTO). Jouttijärvi brings decades of experience …
Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London
April 1, 2026Conferencing, Events & Incentives Cambridge, Cambridge Wide Open Week, London, Oxford
Cambridge Wide Open Week (CWOW) returns from 11-19 June 2026, sharing the spirit and buzz of the week-long, interactive festival …
Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO
April 1, 2026Doccla
Doccla, an AI-powered Proactive Care company, has appointed Michael Macdonnell as Chief Strategy & Growth Officer, and Deputy CEO. As …
Bramacare launches new AI platform to improve eating disorder care
March 31, 2026Market & Product Development AI, Bramacare, eating disorders
Bramacare has launched an AI-enabled platform designed to aid eating disorder and rehabilitation services, the first of its kind in …
Doccla appoints Jonathan Serjeant as Chief Medical Officer
March 31, 2026Doccla
Doccla, an AI-powered Proactive Care company, has appointed Jonathan Serjeant as Chief Medical Officer (CMO). Serjeant brings 25 years of …
SAH Diagnostics opens new diagnostics centre in Bristol
March 30, 2026Health check service Bristol, Bristol Community Diagnostics Hub, SAH Diagnostics
SAH Diagnostics has opened a new privately run diagnostics centre in Bradley Stoke, Bristol, aiming to speed up cancer treatments …
Abselion appoints Dale Gordon as Chair
March 30, 2026Abselion
Abselion has appointed Dale Gordon as Chair of the Board of Directors. Bringing over 30 years of experience to the …
Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month
March 26, 2026Patient Awareness Programmes Bowel Cancer Awareness Month, Stage4You, mental health
Stage4You, a campaign funded and developed by Takeda UK and supported by Bowel Cancer UK, is encouraging patients with stage …
Scotland starts newborn screening for SMA
March 26, 2026Novartis, Scotland, spinal muscular atrophy (SMA)
As part of a two-year evaluation funded by the Scottish government and Novartis, Scotland will screen newborn babies for Spinal …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
